| Year |
Citation |
Score |
| 2021 |
Harizaj A, Descamps B, Mangodt C, Stremersch S, Stoppa A, Balcaen L, Brans T, De Rooster H, Devriendt N, Fraire JC, Bolea-Fernandez E, De Wever O, Willaert W, Vanhaecke F, Stevens CV, ... ... Roman B, et al. Cytosolic delivery of gadolinium photoporation enables improved magnetic resonance imaging of cancer cells. Biomaterials Science. PMID 33899850 DOI: 10.1039/d1bm00479d |
0.402 |
|
| 2018 |
Roman BI, Guedes RC, Stevens CV, García-Sosa AT. Recovering Actives in Multi-Antitarget and Target Design of Analogs of the Myosin II Inhibitor Blebbistatin. Frontiers in Chemistry. 6: 179. PMID 29881723 DOI: 10.3389/Fchem.2018.00179 |
0.485 |
|
| 2018 |
Movsisyan M, Heugebaert T, Roman B, Dams R, Van Campenhout R, Conradi M, Stevens CV. Atom- and mass-economical continuous flow production of 3-chloropropionyl chloride and its subsequent amidation. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 29879290 DOI: 10.1002/Chem.201802208 |
0.651 |
|
| 2018 |
Roman BI, Verhasselt S, Stevens CV. The Medicinal Chemistry and Use of Myosin II Inhibitor ( S)-Blebbistatin and Its Derivatives. Journal of Medicinal Chemistry. PMID 29878759 DOI: 10.1021/Acs.Jmedchem.8B00503 |
0.489 |
|
| 2018 |
Roman BI, Verhasselt S, Mangodt CW, De Wever O, Stevens CV. Synthesis of C-ring-modified blebbistatin derivatives and evaluation of their myosin II ATPase inhibitory potency. Bioorganic & Medicinal Chemistry Letters. PMID 29807794 DOI: 10.1016/J.Bmcl.2018.05.041 |
0.495 |
|
| 2017 |
Verhasselt S, Stevens CV, Van den Broecke T, Bracke ME, Roman BI. Insights into the myosin II inhibitory potency of A-ring-modified (S)-blebbistatin analogs. Bioorganic & Medicinal Chemistry Letters. PMID 28512027 DOI: 10.1016/J.Bmcl.2017.05.008 |
0.506 |
|
| 2017 |
Verhasselt S, Roman BI, Bracke ME, Stevens CV. Improved synthesis and comparative analysis of the tool properties of new and existing D-ring modified (S)-blebbistatin analogs. European Journal of Medicinal Chemistry. 136: 85-103. PMID 28486210 DOI: 10.1016/J.Ejmech.2017.04.072 |
0.522 |
|
| 2017 |
Verhasselt S, Roman BI, De Wever O, Van Hecke K, Van Deun R, Bracke ME, Stevens CV. Discovery of (S)-3'-hydroxyblebbistatin and (S)-3'-aminoblebbistatin: polar myosin II inhibitors with superior research tool properties. Organic & Biomolecular Chemistry. PMID 28220174 DOI: 10.1039/C7Ob00006E |
0.487 |
|
| 2015 |
Roman BI, De Ryck T, Patronov A, Slavov SH, Vanhoecke BW, Katritzky AR, Bracke ME, Stevens CV. 4-Fluoro-3',4',5'-trimethoxychalcone as a new anti-invasive agent. From discovery to initial validation in an in vivo metastasis model. European Journal of Medicinal Chemistry. 101: 627-39. PMID 26204510 DOI: 10.1016/J.Ejmech.2015.06.029 |
0.479 |
|
| 2015 |
Bracke ME, Roman BI, Stevens CV, Mus LM, Parmar VS, De Wever O, Mareel MM. Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds. Journal of Visualized Experiments : Jove. e52792. PMID 26131648 DOI: 10.3791/52792 |
0.434 |
|
| 2015 |
De Ryck T, Vanlancker E, Grootaert C, Roman BI, De Coen LM, Vandenberghe I, Stevens CV, Bracke M, Van de Wiele T, Vanhoecke B. Microbial inhibition of oral epithelial wound recovery: potential role for quorum sensing molecules? Amb Express. 5: 27. PMID 25995981 DOI: 10.1186/S13568-015-0116-5 |
0.398 |
|
| 2015 |
Roman BI, De Ryck T, Verhasselt S, Bracke ME, Stevens CV. Further studies on anti-invasive chemotypes: An excursion from chalcones to curcuminoids. Bioorganic & Medicinal Chemistry Letters. 25: 1021-5. PMID 25666820 DOI: 10.1016/J.Bmcl.2015.01.027 |
0.499 |
|
| 2013 |
Roman BI, De Coen LM, Thérèse F C Mortier S, De Ryck T, Vanhoecke BW, Katritzky AR, Bracke ME, Stevens CV. Design, synthesis and structure-activity relationships of some novel, highly potent anti-invasive (E)- and (Z)-stilbenes. Bioorganic & Medicinal Chemistry. 21: 5054-63. PMID 23867387 DOI: 10.1016/J.Bmc.2013.06.048 |
0.468 |
|
| 2012 |
Heugebaert TS, Roman BI, Stevens CV. Synthesis of isoindoles and related iso-condensed heteroaromatic pyrroles. Chemical Society Reviews. 41: 5626-40. PMID 22782188 DOI: 10.1039/C2Cs35093A |
0.649 |
|
| 2012 |
Roman BI, Ryck TD, Dierickx L, Vanhoecke BW, Katritzky AR, Bracke M, Stevens CV. Exploration of the SAR of anti-invasive chalcones: synthesis and biological evaluation of conformationally restricted analogues. Bioorganic & Medicinal Chemistry. 20: 4812-9. PMID 22743088 DOI: 10.1016/J.Bmc.2012.05.069 |
0.466 |
|
| 2012 |
Maton C, De Vos N, Roman BI, Vanecht E, Brooks NR, Binnemans K, Schaltin S, Fransaer J, Stevens CV. Continuous synthesis of peralkylated imidazoles and their transformation into ionic liquids with improved (electro)chemical stabilities. Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry. 13: 3146-57. PMID 22730073 DOI: 10.1002/Cphc.201200343 |
0.473 |
|
| 2011 |
Aerts D, Verhaeghe TF, Roman BI, Stevens CV, Desmet T, Soetaert W. Transglucosylation potential of six sucrose phosphorylases toward different classes of acceptors. Carbohydrate Research. 346: 1860-7. PMID 21798524 DOI: 10.1016/J.Carres.2011.06.024 |
0.405 |
|
| 2010 |
Roman BI, De Kimpe N, Stevens CV. Synthesis of β-, γ-, δ-, ..., ω-halogenated ketones and aldehydes. Chemical Reviews. 110: 5914-88. PMID 20590147 DOI: 10.1021/Cr900409H |
0.579 |
|
| 2010 |
Claeys DD, Stevens CV, Roman BI, Van De Caveye P, Waroquier M, Van Speybroeck V. Experimental and computational study of the ring opening of tricyclic oxanorbornenes to polyhydro isoindole phosphonates. Organic & Biomolecular Chemistry. 8: 3644-54. PMID 20544085 DOI: 10.1039/C002926B |
0.506 |
|
| 2008 |
Claeys DD, Moonen K, Roman BI, Nemykin VN, Zhdankin VV, Waroquier M, Van Speybroeck V, Stevens CV. Synthesis of tricyclic phosphonopyrrolidines via IMDAF: experimental and theoretical investigation of the observed stereoselectivity. The Journal of Organic Chemistry. 73: 7921-7. PMID 18785707 DOI: 10.1021/Jo801138S |
0.477 |
|
| Show low-probability matches. |